AVR · XBRL financial data
Anteris Technologies Global financial statements, every fiscal year
The same tables from 2 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (AVR's year ends in late December)
| In thousands of dollars | Dec 31, 2025 |
|---|---|
| Revenue from contracts with customers | 1,913 |
| Cost of goods and services sold | 569 |
| Research and development | 69,120 |
| Selling, general and administrative | 26,118 |
| Operating income (loss) | (93,894) |
| Interest expense | 73 |
| Other income (expense) | 467 |
| Income tax expense (benefit) | 0 |
| Net income (loss) | (94,144) |
| Earnings per share, basic USD per share | (2.55) |
| Earnings per share, diluted USD per share | (2.55) |
| Weighted average shares, basic thousands of shares | 36,911 |
| Weighted average shares, diluted thousands of shares | 36,911 |
Balance sheet
CSVFiscal years (AVR's year ends in late December)
| In thousands of dollars | Dec 31, 2025 |
|---|---|
| Cash and cash equivalents | 6,697 |
| Accounts receivable | 32 |
| Inventory | 152 |
| Total current assets | 15,676 |
| Property and equipment, net | 5,261 |
| Right-of-use asset | 1,995 |
| Total assets | 22,997 |
| Accounts payable | 11,094 |
| Accrued liabilities | 3,425 |
| Total current liabilities | 21,373 |
| Lease liability, non-current | 1,678 |
| Total liabilities | 23,250 |
| Accumulated deficit | (370,532) |
| Total stockholders' equity | (93) |
| Total liabilities and equity | 22,997 |
| Common shares outstanding (cover page) thousands of shares | 97,232 |
Cash flows
CSVFiscal years (AVR's year ends in late December)
| In thousands of dollars | Dec 31, 2025 |
|---|---|
| Net income (loss) | (94,144) |
| Stock-based compensation | 7,783 |
| Depreciation and amortization | 1,661 |
| Net cash from operating activities | (77,803) |
| Purchases of property and equipment | 1,954 |
| Net cash from investing activities | (596) |
| Proceeds from issuing common stock | 25,819 |
| Proceeds from issuing equity | 230,000 |
| Net cash from financing activities | 20,555 |
| Net change in cash | (57,882) |
Compare with peers
SIC 3842 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 3842 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
| Company | Cash ($K) | Revenue, quarter ($K) | Operating cash flow, quarter ($K) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Anteris Technologies Global | 249,904 | 1,009 | (20,797)* | 97.5M | 12.0 quarters | 10-QJun 30, 2026 |
| Catheter Precision | 643 | 1,019 | (2,861)* | 14.4M | 0.6 quarters | 10-QJun 30, 2026 |
| RenovoRx | 9,479 | 909 | (2,867)* | 45.1M | 3.3 quarters | 10-QJun 30, 2026 |
| Adm Tronics Unlimited | 223 | not reported | (33) | 67.6M | 6.8 quarters | 10-QJun 30, 2026 |
| QHSLab | 317 | 847 | (7.8)* | 15.0M | 40.6 quarters | 10-QJun 30, 2026 |
| Tenon Medical | 1,677 | 1,279 | (2,758)* | 667,047 | 0.6 quarters | 10-QJun 30, 2026 |
| Lucid Diagnostics | 33,404 | not reported | (11,297)* | 203.2M | 3.0 quarters | 10-QJun 30, 2026 |
| Encision | 72 | 1,528 | (127)* | 16.9M | 0.6 quarters | 10-QSep 30, 2025 |
| SeaStar Medical Holding | 6,959 | 615 | (2,994)* | 4.4M | 2.3 quarters | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.